Jefferies Maintains a 'Hold' on Walgreen (WAG); Goodbye TRICARE
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Jefferies Reiterates a 'Buy' on Express Scripts (ESRX); On Track With Narrow Network Strategy
September 6, 2012 7:23 AM EDTJefferies reiterates a 'Buy' on Express Scripts (NASDAQ: ESRX) price target of $70.00.
Analyst, Brian Tanquilut, said, "TRICARE's decision to stick with a narrow pharmacy network that excludes Walgreen's (NYSE: WAG) provides strong validation for ESRX's limited network... More
